Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2004, p. 3692-3702, Vol. 24, No. 9
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.9.3692-3702.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Satoshi Hirose, Reiko Hayashi, and Hitoshi Sakano*
Department of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan
Received 27 October 2003/ Returned for modification 4 December 2003/ Accepted 2 February 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
In the joining phase of V(D)J recombination, CEs are processed and ligated to form a coding joint. Several factors are required in DNA end joining, including the Ku heterodimer (Ku70/80), the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), Artemis, XRCC4, and DNA ligase IV (4, 11, 14, 15, 27, 28, 34, 38, 42, 43, 54, 61). It has been shown that the Artemis/DNA-PKcs complex opens the hairpin a few nucleotides from the tip, generating the 3'-overhanging structure (30, 50). After the hairpin opening, the CEs are modified by nucleotide deletions and additions for junctional diversification (50). For nucleotide additions, terminal deoxynucleotidyltransferase (TdT) has been reported to be responsible for the non-germ line encoded nucleotides (N) (13, 24). In contrast, the exact mechanism for the nucleotide deletions remains largely unknown. The RAG proteins are known to mediate the strand transfer of the SE to the hairpin CE or to the double-stranded (ds) DNA, resulting in the aberrant joining products in vitro (3, 19, 26, 32). The 3' flap endonuclease activity was also reported for the RAG proteins and was suggested to be a candidate for the CE processing activity (47). However, this activity was SE independent and requires Mn2+.
In the present study, we examined the SE complex for the 3'-processing activity using 3'-overhanging DNA. This is because the RAG proteins remain bound to the SEs in vivo even after the RSS has been cleaved (2, 40). Here, we report that the RAG proteins in the SE complex can process and cleave the 3' overhang of the ds DNA in vitro in two successive steps.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
-32P]ATP (Amersham Biosciences) by using T4 polynucleotide kinase (New England Biolabs) or 3' end labeled by annealing with appropriate complementary oligonucleotide and filling in 1 nt with [
-32P] dGTP or [
-32P]dCTP (Amersham Biosciences) by using a Klenow fragment (3' exo; New England Biolabs). To prepare the 3'-dideoxy oligonucleotide, the oligonucleotide was extended with ddCTP or ddGTP (Roche Diagnostics) by using terminal deoxyribonucleotide transferase (Roche Diagnostics). An internally labeled strand was prepared by ligating the 5'-32P-labeled 3' half (5'-GAGTCAGCTGCAACCCTAGGAGGTTTTTGTTCAGCCCTGGAGCACTGTG-3') to the unlabeled 5' half (5'-GACCTAATAC-3') in the presence of the complementary strand by using T4 DNA ligase (New England Biolabs). The labeled oligonucleotide was purified from a denaturing polyacrylamide gel and reannealed to the indicated complementary strand. Annealed DNA was further purified by electrophoresis in an 8% polyacrylamide gel, eluted from gel slices with an elution buffer (0.2 M NaCl, 1 mM EDTA, and 20 mM Tris-HCl [pH 7.5]), and purified with reversed-phase column chromatography (Elutip-d; Schleicher & Schuell). 3'-Processing reactions. To examine the SE requirements, 12-SE DNA (8 nM) and 23-SE DNA (8 nM) were incubated with RAG1 (10 µg/ml), RAG2 (10 µg/ml), and HMG1 (8 µg/ml) proteins at 37°C for 120 min in binding buffer (25 mM MOPS [morpholinepropanesulfonic acid]-KOH [pH 7.0], 5 mM Tris-HCl [pH 8.0], 2.4 mM DTT, 90 mM potassium acetate, 30 mM KCl, 0.1 mg of bovine serum albumin [BSA]/ml, and 2% glycerol) containing 10 mM MgCl2. The labeled ds DNA (200 cpm/µl) was added and incubated at 37°C for 60 min. In all other experiments, the unlabeled or labeled 12-SE DNA (20 nM or 200 cpm/µl, respectively) and its partner biotinylated 23-SE DNA (20 or 8 nM, respectively) were incubated with RAG1 (10 µg/ml), RAG2 (10 µg/ml), and HMG1 (8 µg/ml) proteins at 37°C for 100 min in 20 µl of the binding buffer containing 10 mM CaCl2. Streptavidin-coated magnetic beads (Dynabeads M-280; 10 µg/µl) were added, and the reaction mixture was incubated at 37°C for 20 min. After incubation, magnetic beads and supernatant were separated by use of a magnet stand. The beads were washed four times at room temperature with 30 µl of binding buffer containing 10 mM CaCl2 and resuspended in the binding buffer containing Mg2+ (10 mM if not otherwise specified). The labeled or unlabeled substrate ds DNA (200 cpm/µl or 5 nM, respectively) was added to the SE complex and incubated at 37°C. To examine the effect of the Mg2+ concentration, the SE complex was reconstituted and isolated with 1 mM CaCl2 instead of 10 mM CaCl2. DNA was extracted from the reaction mixture by using phenol-chloroform-isoamyl alcohol (25:24:1), precipitated with ethanol, washed with 70% ethanol, dissolved in formamide dye mix, and electrophoresed in a denaturing polyacrylamide gel.
Transposition. The SE complex was reconstituted by using the biotinylated 12-SE DNA (16 nM) and the labeled 23-SE DNA (12 nM) in a buffer containing 1 mM MgCl2, 25 mM MOPS-KOH (pH 7.0), 5 mM Tris-HCl (pH 8.0), 2.8 mM DTT, 60 mM potassium acetate, 60 mM NaCl, 1 mg of BSA/ml, and 8% glycerol. The bead-bound SE complex was washed three times with wash buffer (25 mM MOPS-KOH [pH 7.0], 2.4 mM DTT, 90 mM potassium acetate, 210 mM KCl, 1 mg of BSA/ml, and 2% glycerol) and once with a Tn buffer (25 mM MOPS-KOH [pH 7.0], 2.4 mM DTT, 45 mM potassium acetate, 30 mM KCl, 0.1 mg of BSA/ml, and 2% glycerol). The amount of the isolated SE complex was estimated by a count of the 32P incorporated into the complex. The target plasmid (pBluescript II SK [Stratagene]) (25 ng/µl) was incubated with the SE complex (0.1 nM) at 37°C in the Tn buffer containing 3 mM MgCl2. After the transposition reaction, sodium dodecyl sulfate (0.5%) and proteinase K (1 mg/ml) (Roche Diagnostics) were added and incubated at 55°C for 60 min. DNA was extracted from the reaction mixture by using phenol-chloroform-isoamyl alcohol (25:24:1), precipitated with ethanol, resuspended in a Tris-EDTA buffer, electrophoresed in a 1% Tris-acetate-EDTA agarose gel, transferred to a nylon membrane filter, and autoradiographed. The SE complex was reconstituted with the unlabeled 23-SE DNA in parallel and assayed for the 3'-processing activity in the Tn buffer containing 3 mM MgCl2.
Isolation of the complexes containing ST intermediates. After the 3'-processing reaction, the complex was reisolated with magnetic beads from the reaction mixture and washed once with the wash buffer containing 1 mM CaCl2 and four times with the Ca2+-free wash buffer. The isolated complex was resuspended in the binding buffer containing 10 mM MgCl2.
Enzymatic treatments of reaction products. For the calf intestine alkaline phosphatase (CIP) treatment, DNA extracted from the reaction mixture was incubated at 37°C for 30 min with 0.5 U of CIP (Roche Diagnostics) in the manufacturer's buffer. For the T4 polynucleotide kinase treatment, DNA was incubated with 2 U of polynucleotide kinase in the manufacturer's buffer at 37°C for 30 min. For restriction enzyme treatment, DNA was incubated at 37°C for 120 min with 1 U of PvuII or BsrGI (TaKaRa Biochemicals) in the manufacturer's buffer. For the exonuclease V (exoV) treatment, DNA was incubated at 37°C for 120 min with 2 U of exoV (Amersham Biosciences) in 67 mM glycine-NaOH (pH 9.4)-10 mM ß-mercaptoethanol-6.7 mM MgCl2.
Purification and endonuclease treatment of each cleavage product. Each cleavage product was separated by electrophoresis in a 15% denaturing polyacrylamide gel and eluted from the gel slice with the elution buffer. DNA was precipitated with ethanol, washed with 70% ethanol, dissolved in a Tris-EDTA buffer, and treated at 25°C for 10 min with mung bean nuclease (3.56, 10.7, or 32 U/ml) (TaKaRa Biochemicals) in 50 mM Tris-HCl (pH 5.2)-30 mM NaCl-10 mM ZnSO4. DNA was extracted by phenol-chloroform-isoamyl alcohol (25:24:1), concentrated by 1-butanol extraction, dissolved in formamide dye mix, and electrophoresed in a 16.5% denaturing polyacrylamide gel.
| RESULTS |
|---|
|
|
|---|
|
|
|
To demonstrate the resolution process more directly, we reconstituted the SE complex with the 12-ST instead of the 12-SE. The 12-ST DNA was labeled with 32P at the 5' end of the bottom strand, paired with the 23-SE, and incubated with the RAG1, RAG2, and HMG1 proteins in the Mg2+-containing buffer. The ST band of 58 nt (bottom strand) was converted to the 12-SE of 48 nt (Fig. 4A). Even STs with overhangs as short as 1 nt were cleaved (data not shown). We then labeled the 12-ST at the 3'-terminal nucleotide of the bottom strand and performed the same cleavage reaction. This time, two faster migrating cleavage products (X and Y) appeared (Fig. 4A). The band Y showed the electrophoretic mobility expected for the cleavage product of the 12-ST nicked at the ds/ss junction. The other product, band X, was assumed to be the circular form of the linear cleavage product, band Y (see below). Similar cleavage products were also generated from the labeled 23-ST when it was paired with the 12-SE (data not shown). The cleavage of the 12-ST was significantly reduced when the 12/23 rule was violated by pairing with the 12-SE (Fig. 4A). These results indicate that the 3' overhang in the ST, transferred from ds DNA to the SE, is indeed cleaved in the SE complex. We examined whether the resolution reaction is HMG dependent. It was found that the HMG protein is dispensable in the ST cleavage reaction (data not shown). Although HMG slightly stimulates the ST cleavage, this could be due to the stimulating effect of the HMG on the SE complex reconstitution rather than on the catalysis.
|
|
| DISCUSSION |
|---|
|
|
|---|
The 3'-processing reaction is similar to but distinct from the transposition and disintegration reaction. The first step in the 3'-processing reaction can be regarded as the initial transposition reaction targeting the distorted DNA structure (26, 55). However, the 3'-processing and transposition reactions are different in the subsequent steps. The transpositional strand transfer to the ds DNA is followed by the reversal reaction that removes the SE from the transposition product and reseals the target DNA (33). This reaction was proposed to explain at least in part why the RAG-mediated transposition does not usually occur in cells (33). In contrast, strand transfer to the 3' overhang is followed by the release of the 3'-processed ds DNA and by the hydrolysis-mediated resolution of the ST intermediate, accumulating the cleavage products.
It should be noted that the C-terminal region of the full-length RAG2 has different effects on the 3'-processing and the transposition and disintegration reactions: the 3'-processing activity was not affected by the presence of the C-terminal region of RAG2, whereas the transposition activity was significantly reduced (Fig. 6) (57). We suppose that the presence of the C-terminal region of RAG2 may interfere with the accessibility of the target ds DNA (9, 57), but not with the 3'-overhanging end. It is possible that the C-terminal region of the RAG2 may play a role in preventing the harmful transposition in cells (9, 51, 57) while maintaining the 3'-processing activity.
Implication for the junctional diversification in V(D)J joining. It is important to determine that the 3'-processing activity detected in vitro in the present study plays a role in processing the hairpin-opened CEs in vivo. It has been reported that the hairpin opening yields mainly the 3'-overhanging structure in the CE (7, 29, 30, 49). Since the 3' overhang can be cleaved at variable sites near the ds/ss junction in vitro (Fig. 1), this cleavage, if it also occurs in vivo, may contribute to the diversity at the junctional sequences of antigen receptor genes. In contrast, the cleavage on the ST occurs precisely at the ds/ss junction (Fig. 4). Restoration of the blunt-end structure at the SE is consistent with the observation that most signal joints do not contain any nucleotide addition or deletion (50).
In the double-strand break repair, nucleotide removal is usually necessary to tailor the DNA ends suitable for ligation. It has been reported that the Artemis/DNA-PKcs complex possesses the 3' and 5' overhang endonuclease activities that may be involved in the repair and processing of the CEs (30). Variable CE processing may require other nucleases with different cleavage site preferences. Since the SE complex tends to cleave at sites in the 3' overhang that are more 5' than those of Artemis/DNA-PKcs (30), it could contribute more junctional diversity than the Artemis/DNA-PKcs alone, if the SE complex is actually involved in the CE processing in vivo.
To examine the CE processing by the SE complex in vivo, mutant RAGs defective in the 3'-processing activity will be helpful. Reconstitution of the postcleavage processes in vitro, which depend on repair factors such as Ku, will also be necessary. Although these attempts are now under way, some recent findings are encouraging. First, studies with the mutant RAGs have suggested that the RAG proteins may play an architectural role in the postcleavage phase of V(D)J recombination (20, 56). If this is the case, the RAG proteins are likely to associate with or stay near the CEs in the SE complex (2, 18, 40). Second, unlike the 3' flap endonuclease, the 3'-processing activity of the SE complex is high when Mg2+ is present in vitro (Fig. 1B). Third, among the known strand transfer activities of the SE complex, only the 3' processing could have a physiologic role, preventing a potentially harmful transposition in cells. Finally, the 3'-processing activity is not affected by the presence of the C-terminal region of the RAG2 (Fig. 6), while the transposition activity is significantly reduced (57). The C-terminal region of the RAG2 may be important in preventing the harmful transposition (9, 51, 57) while maintaining the CE processing activity, although it has yet to be verified that this occurs in cells.
The RAG-mediated transposition can be found in Saccharomyces cerevisiae cells (5) but rarely occurs in the mammalian cells. However, the SE complex appears to possess the strand transfer activity in the mammalian cells, because the RAG-mediated hybrid joining has been reported for the extrachromosomal recombination with the truncated RAG proteins (16, 51). A similar observation was also made for the antigen receptor loci in the Ku gene knockout mice where the hairpin CEs accumulate (4, 61). The hybrid joining may result from the unregulated strand transfer of the SE on the CEs before hairpin opening.
V(D)J recombination may be a reversal of an accidental insertion of a transposable element into a primordial V gene, which was exploited later by the vertebrate immune system during evolution (45). In the initial phase of V(D)J joining, the RAG proteins cleave the RSS by a mechanism similar to that of transposition or that of retroviral integration (22, 58). The SE complex has been reported to possess the transposition activity in vitro, while such harmful transpositional strand transfer is rarely seen in vivo. It is tempting to assume that the strand transfer activity of RAG proteins is utilized to diversify the antigen receptor genes in V(D)J joining by removing the 3' overhang from the hairpin-opened CEs. However, this, of course, must be verified in the in vivo system in the future.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from Japan Science and Technology Corporation, the Ministry of Education, Culture and Science, and the Mitsubishi Foundation.
| FOOTNOTES |
|---|
Present address: Radiobiology Division, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Agrawal, A., and D. G. Schatz. 1997. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell 89:43-53.[CrossRef][Medline]
3. Agrawal, A., Q. M. Eastman, and D. G. Schatz. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394:744-751.[CrossRef][Medline]
4. Bogue, M. A., C. Wang, C. Zhu, and D. B. Roth. 1997. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity 7:37-47.[CrossRef][Medline]
5. Clatworthy, A. E., M. A. Valencia, J. E. Haber, and M. A. Oettinger. 2003. V(D)J recombination and RAG-mediated transposition in yeast. Mol. Cell 12:489-499.[CrossRef][Medline]
6. Difilippantonio, M. J., C. J. McMahan, Q. M. Eastman, E. Spanopoulou, and D. G. Schatz. 1996. RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination. Cell 87:253-262.[CrossRef][Medline]
7. Ding, Q., Y. V. Reddy, W. Wang, T. Woods, P. Douglas, D. A. Ramsden, S. P. Lees-Miller, and K. Meek. 2003. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol. Cell. Biol. 23:5836-5848.
8. Eastman, Q. M., T. M. Leu, and D. G. Schatz. 1996. Initiation of V(D)J recombination in vitro obeying the 12/23 rule. Nature 380:85-88.[CrossRef][Medline]
9. Elkin, S. K., A. G. Matthews, and M. A. Oettinger. 2003. The C-terminal portion of RAG2 protects against transposition in vitro. EMBO J. 22:1931-1938.[CrossRef][Medline]
10. Engelman, A., K. Mizuuchi, and R. Craigie. 1991. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67:1211-1221.[CrossRef][Medline]
11. Frank, K. M., J. M. Sekiguchi, K. J. Seidl, W. Swat, G. A. Rathbun, H. L. Cheng, L. Davidson, L. Kangaloo, and F. W. Alt. 1998. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 396:173-177.[CrossRef][Medline]
12. Fugmann, S. D., I. J. Villey, L. M. Ptaszek, and D. G. Schatz. 2000. Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex. Mol. Cell 5:97-107.[CrossRef][Medline]
13. Gilfillan, S., A. Dierich, M. Lemeur, C. Benoist, and D. Mathis. 1993. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 261:1175-1178.
14. Grawunder, U., D. Zimmer, S. Fugmann, K. Schwarz, and M. R. Lieber. 1998. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol. Cell 2:477-484.[CrossRef][Medline]
15. Gu, Y., S. Jin, Y. Gao, D. T. Weaver, and F. W. Alt. 1997. Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc. Natl. Acad. Sci. USA 94:8076-8081.
16. Han, J. O., S. B. Steen, and D. B. Roth. 1997. Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol. Cell. Biol. 17:2226-2234.[Abstract]
17. Hiom, K., and M. Gellert. 1997. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage. Cell 88:65-72.[CrossRef][Medline]
18. Hiom, K., and M. Gellert. 1998. Assembly of a 12/23 paired signal complex: a critical control point in V(D)J recombination. Mol. Cell 1:1011-1019.[CrossRef][Medline]
19. Hiom, K., M. Melek, and M. Gellert. 1998. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell 94:463-470.[CrossRef][Medline]
20. Huye, L. E., M. M. Purugganan, M. M. Jiang, and D. B. Roth. 2002. Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase. Mol. Cell. Biol. 22:3460-3473.
21. Jones, J. M., and M. Gellert. 2001. Intermediates in V(D)J recombination: a stable RAG1/2 complex sequesters cleaved RSS ends. Proc. Natl. Acad. Sci. USA 90:12926-12931.
22. Kennedy, A. K., A. Guhathakurta, N. Kleckner, and D. B. Haniford. 1998. Tn10 transposition via a DNA hairpin intermediate. Cell 95:125-134.[CrossRef][Medline]
23. Kim, D. R., Y. Dai, C. L. Mundy, W. Yang, and M. A. Oettinger. 1999. Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. Genes Dev. 13:3070-3080.
24. Komori, T., A. Okada, V. Stewart, and F. W. Alt. 1993. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 261:1171-1175.
25. Landree, M. A., J. A. Wibbenmeyer, and D. B. Roth. 1999. Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination. Genes Dev. 13:3059-3069.
26. Lee, G. S., M. B. Neiditch, R. R. Sinden, and D. B. Roth. 2002. Targeted transposition by the V(D)J recombinase. Mol. Cell. Biol. 22:2068-2077.
27. Li, Z., T. Otevrel, Y. Gao, H.-L. Cheng, B. Seed, T. D. Stamato, G. E. Taccioli, and F. W. Alt. 1995. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 83:1079-1089.[CrossRef][Medline]
28. Lieber, M., J. E. Hesse, S. Lewis, G. C. Bosma, N. Rosenberg, K. Mizuuchi, M. J. Bosma, and M. Gellert. 1988. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 55:7-16.[CrossRef][Medline]
29. Livak, F., and D. G. Schatz. 1997. Identification of V(D)J recombination coding end intermediates in normal thymocytes. J. Mol. Biol. 267:1-9.[CrossRef][Medline]
30. Ma, Y., U. Pannicke, K. Schwarz, and M. R. Lieber. 2002. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108:781-794.[CrossRef][Medline]
31. McBlane, J. F., D. C. van Gent, D. A. Ramsden, C. Romeo, C. A. Cuomo, M. Gellert, and M. A. Oettinger. 1995. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83:387-395.[CrossRef][Medline]
32. Melek, M., M. Gellert, and D. C. van Gent. 1998. Rejoining of DNA by the RAG1 and RAG2 proteins. Science 280:301-303.
33. Melek, M., and M. Gellert. 2000. RAG1/2-mediated resolution of transposition intermediates: two pathways and possible consequences. Cell 101:625-633.[CrossRef][Medline]
34. Moshous, D., I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana-Calvo, F. Le Deist, I. Tezcan, O. Sanal, Y. Bertrand, N. Philippe, A. Fischer, and J. P. de Villartay. 2001. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177-186.[CrossRef][Medline]
35. Nagawa, F., K. Ishiguro, A. Tsuboi, T. Yoshida, A. Ishikawa, T. Takemori, A. J. Otsuka, and H. Sakano. 1998. Footprint analysis of the RAG protein recombination signal sequence complex for V(D)J type recombination. Mol. Cell. Biol. 18:655-663.
36. Nagawa, F., M. Kodama, T. Nishihara, K. Ishiguro, and H. Sakano. 2002. Footprint analysis of recombination signal sequences in the 12/23 synaptic complex of V(D)J recombination. Mol. Cell. Biol. 22:7217-7225.
37. Neiditch, M. B., G. S. Lee, M. A. Landree, and D. B. Roth. 2001. RAG transposase can capture and commit to target DNA before or after donor cleavage. Mol. Cell. Biol. 21:4302-4310.
38. Nussenzweig, A., C. Chen, V. da Costa Soares, M. Sanchez, K. Sokol, M. C. Nussenzweig, and G. C. Li. 1996. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382:551-555.[CrossRef][Medline]
39. Oettinger, M. A., D. G. Schatz, C. Gerka, and D. Baltimore. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517-1523.
40. Perkins, E. J., A. Nair, D. O. Cowley, T. Van Dyke, Y. Chang, and D. A. Ramsden. 2002. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev. 16:159-164.
41. Qiu, J. X., S. B. Kale, H. Yarnell Schultz, and D. B. Roth. 2001. Separation-of-function mutants reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination. Mol. Cell 7:77-87.[CrossRef][Medline]
42. Rooney, S., J. Sekiguchi, C. Zhu, H. L. Cheng, J. Manis, S. Whitlow, J. DeVido, D. Foy, J. Chaudhuri, D. Lombard, and F. W. Alt. 2002. Leaky Scid phenotype associated with defective V(D)J. coding end processing in Artemis-deficient mice. Mol. Cell 10:1379-1390.[CrossRef][Medline]
43. Roth, D. B., J. P. Menetski, P. B. Nakajima, M. J. Bosma, and M. Gellert. 1992. V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell 70:983-991.[CrossRef][Medline]
44. Sadofsky, M. J. 2001. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 29:1399-1409.
45. Sakano, H., K. Huppi, G. Heinrich, and S. Tonegawa. 1979. Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature 280:288-294.[CrossRef][Medline]
46. Sakano, H., R. Maki, Y. Kurosawa, W. Roeder, and S. Tonegawa. 1980. Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature 286:676-683.[CrossRef][Medline]
47. Santagata, S., E. Besmer, A. Villa, F. Bozzi, J. S. Allingham, C. Sobacchi, D. B. Haniford, P. Vezzoni, M. C. Nussenzweig, Z. Q. Pan, and P. Cortes. 1999. The RAG1/RAG2 complex constitutes a 3' flap endonuclease: implications for junctional diversity in V(D)J and transpositional recombination. Mol. Cell 4:935-947.[CrossRef][Medline]
48. Schatz, D. G., M. A. Oettinger, and D. Baltimore. 1989. The V(D)J recombination activating gene, RAG-1. Cell 59:1035-1048.[CrossRef][Medline]
49. Schlissel, M. S. 1998. Structure of nonhairpin coding-end DNA breaks in cells undergoing V(D)J recombination. Mol. Cell. Biol. 18:2029-2037.
50. Schlissel, M. S. 2002. Does artemis end the hunt for the hairpin-opening activity in V(D)J recombination? Cell 109:1-4.[CrossRef][Medline]
51. Sekiguchi, J. A., S. Whitlow, and F. W. Alt. 2001. Increased accumulation of hybrid V(D)J joins in cells expressing truncated versus full-length RAGs. Mol. Cell 8:1383-1390.[CrossRef][Medline]
52. Spanopoulou, E., F. Zaitseva, F. H. Wang, S. Santagata, D. Baltimore, and G. Panayotou. 1996. The homeodomain region of Rag-1 reveals the parallel mechanisms of bacterial and V(D)J recombination. Cell 87:263-276.[CrossRef][Medline]
53. Swanson, P. C., and S. Desiderio. 1998. V(D)J recombination signal recognition: distinct, overlapping DNA-protein contacts in complexes containing RAG1 with and without RAG2. Immunity 9:115-125.[CrossRef][Medline]
54. Taccioli, G. E., G. Rathbun, E. Oltz, T. Stamato, P. A. Jeggo, and F. W. Alt. 1993. Impairment of V(D)J recombination in double-strand break repair mutants. Science 260:207-210.
55. Tsai, C. L., M. Chatterji, and D. G. Schatz. 2003. DNA mismatches and GC-rich motifs target transposition by the RAG1/RAG2 transposase. Nucleic Acids Res. 31:6180-6190.
56. Tsai, C. L., A. H. Drejer, and D. G. Schatz. 2002. Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination. Genes Dev. 16:1934-1949.
57. Tsai, C. L., and D. G. Schatz. 2003. Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2. EMBO J. 22:1922-1930.[CrossRef][Medline]
58. van Gent, D. C., K. Mizuuchi, and M. Gellert. 1996. Similarities between initiation of V(D)J recombination and retroviral integration. Science 271:1592-1594.[Abstract]
59. van Gent, D. C., D. A. Ramsden, and M. Gellert. 1996. The RAG1 and RAG2 proteins establish the 12/23 rule in V(D)J recombination. Cell 85:107-113.[CrossRef][Medline]
60. Yarnell Schultz, H., M. A. Landree, J. X. Qiu, S. B. Kale, and D. B. Roth. 2001. Joining-deficient RAG1 mutants block V(D)J recombination in vivo and hairpin opening in vitro. Mol. Cell 7:65-75.[CrossRef][Medline]
61. Zhu, C., M. A. Bogue, D.-S. Lim, P. Hasty, and D. B. Roth. 1996. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86:379-389.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|